Pharmacological inhibition of AIMP2 aggregation attenuates α-synuclein aggregation and toxicity in Parkinson's disease.
Shin JY, Lee B, Ham S, Kim JH, Kim H, Kim H, Jo MG, Kim HJ, Park SW, Kweon HS, Kim YJ, Yun SP, Lee Y.
Shin JY, et al. Among authors: kim h, kim yj, kim hj, kim jh.
Biomed Pharmacother. 2022 Dec;156:113908. doi: 10.1016/j.biopha.2022.113908. Epub 2022 Oct 22.
Biomed Pharmacother. 2022.
PMID: 36283223
Free article.